Vindeep Pharmaceuticals Private Limited
About Vindeep Pharmaceuticals Private Limited
Data last updated:
Vindeep Pharmaceuticals Private Limited is a private limited company based in Thane, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 25 January 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24100MH2021PTC354102.
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹10 Lakh. It is led by directors Vinod Harbanslal Kheterpal and Abhirup Vinod Kheterpal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 1 Sandeep Apt Naupada, Thane, Maharashtra, India – 400602.
As per the financials filed for FY 2025, the company reported a revenue of ₹69,605, a growth of 26% compared to the previous year. For the same year it recorded a net profit of ₹46,938 (net margin 67.4%) and EBITDA of ₹59,605 (EBITDA margin 85.6%).
Company details
Contact details
Vindeep Pharmaceuticals Private Limited's registered office is in Thane, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address1 Sandeep Apt Naupada, Thane, Maharashtra, India – 400602
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Vindeep Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Vindeep Pharmaceuticals Private Limited
FY 2025 filings availableVindeep Pharmaceuticals Private Limited reported revenue of ₹69,605 (up 26% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 26% in the latest year. EBITDA rose 633% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹59,605 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹46,938 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 85.6% | ||||
| Net Profit Margin | 67.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Vindeep Pharmaceuticals Private Limited, buy the company report.
Board of directors of Vindeep Pharmaceuticals Private Limited
Vindeep Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vinod Harbanslal Kheterpal Also directs: Shree Bhairav Synthetics Pvt Ltd, Sunvin Industries Private Limited, Shiv Ashish Processors Private Limited and 5 more | Director | 25 Jan 2021 | 5 Years 8 Months | Current |
| Abhirup Vinod Kheterpal Also directs: Shree Bhairav Synthetics Pvt Ltd, Sushmita Synthetics P Ltd, Shri Shivkrupa Synthetics Private Limited and 3 more | Director | 25 Jan 2021 | 5 Years 8 Months | Current |
Peer comparison
Vindeep Pharmaceuticals Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Lawrence Pharmaceuticals Private Limited | ₹73,000 (FY 2016) | -70.0% | Patna, Bihar, India | |||
| Lijek Pharmaceuticals Private Limited | ₹72,400 (FY 2025) | 38.0% | Noida, Uttar Pradesh, India | |||
| Pinnace Pharmaceuticals Private Limited | ₹71,701 (FY 2022) | Zirakpur, Punjab, India | ||||
| Aerocure Pharmaceuticals Private Limited | ₹70,707 (FY 2024) | Delhi, India | ||||
| Vitthal Pharmaceuticals Private Limited | ₹69,976 (FY 2025) | -90.0% | Agra, Uttar Pradesh, India | |||
| Vindeep Pharmaceuticals Private Limitedthis company | ₹69,605 (FY 2025) | ₹46,938 | 67.4% | 26.0% | Thane, Maharashtra, India | |
| Camerin Drugs and Pharmaceuticals Ltd | ₹69,127 (FY 2019) | -83.0% | Cannanore, Kerala, India | |||
| Chromogenics Pharmaceuticals Private Limited | ₹69,000 (FY 2018) | -87.0% | Varanasi, Uttar Pradesh, India | |||
| Uphill Pharmaceuticals Private Limited | ₹68,400 (FY 2020) | -2.0% | New Delhi, Delhi, India | |||
| Benzoic Pharmaceuticals Private Limited | ₹68,140 (FY 2024) | Kolkata, West Bengal, India | ||||
| Mediclay Pharmaceuticals Private Limited | ₹67,123 (FY 2024) | 126.0% | Delhi, India |
To see the full peer comparison of Vindeep Pharmaceuticals Private Limited, buy the company report.
Auditor
Vindeep Pharmaceuticals Private Limited is audited by RANJAN NEHAL & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RANJAN NEHAL & ASSOCIATES | FY 2023 | 0151015W |
Shareholding
The shareholding of Vindeep Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Vindeep Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Vindeep Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Vindeep Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Vindeep Pharmaceuticals Private Limited has 1 active EPFO establishment as of Apr 09, 2024.
GST
No GST registration is on our record for Vindeep Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Vindeep Pharmaceuticals Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Abhirup Vinod Kheterpal was appointed as Director on 25 Jan 2021.
Frequently asked questions
Vindeep Pharmaceuticals is an active private limited company based in Thane, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 25 January 2021 (5+ years old) and is registered under CIN U24100MH2021PTC354102.
Vindeep Pharmaceuticals has 2 current directors:
- Vinod Harbanslal Kheterpal - Director
- Abhirup Vinod Kheterpal - Director
The latest financial statements of Vindeep Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The CIN (Corporate Identification Number) of Vindeep Pharmaceuticals is U24100MH2021PTC354102. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Vindeep Pharmaceuticals was incorporated on 25 January 2021, making it 5+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Vindeep Pharmaceuticals by revenue are Lawrence Pharmaceuticals Private Limited, Lijek Pharmaceuticals Private Limited, Pinnace Pharmaceuticals Private Limited, Aerocure Pharmaceuticals Private Limited, Vitthal Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Abhirup Vinod Kheterpal was appointed as Director on 25 Jan 2021. Vinod Harbanslal Kheterpal was appointed as Director on 25 Jan 2021.
The registered office of Vindeep Pharmaceuticals is at 1 Sandeep Apt Naupada, Thane, Maharashtra, India – 400602.
Vindeep Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
Vindeep Pharmaceuticals can be reached at its registered office: 1 Sandeep Apt Naupada, Thane, Maharashtra, India – 400602.
Vindeep Pharmaceuticals is registered under the jurisdiction of the Registrar of Companies (ROC), Mumbai.